Pharmacons ApS: Financial statements 2020
CVR: 36892870
Source: annual report 2020, Danish Business Authority
01/05/2019 – 30/04/2020
Pharmacons ApS (CVR 36892870) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 22,063 and a net result of DKK 20,172 compared with DKK 43,511 the year before. That is a decrease of 73.6% compared with the year before. Equity in the 2020 report amounted to DKK 183,908. The solvency ratio was 77%.
- Gross Profit
- DKK 22,063
- Profit/Loss
- DKK 20,172
- Equity
- DKK 183,908
- Total Assets
- DKK 238,787
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 22 t. | 20 t. | 184 t. | - |
| 2019 | - | 83 t. | 44 t. | 164 t. | 1 |
| 2018 | - | 4 t. | -120 t. | 120 t. | 1 |
| 2017 | - | 327 t. | 180 t. | 240 t. | 1 |
| 2016 | 372 t. | - | 11 t. | 61 t. | - |
Official annual report
How creditworthy is Pharmacons ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout Pharmacons ApS
Pharmacons ApS was a Danish company of the type Anpartsselskab based in Helsingør, founded in 2015. The company has been dissolved on 26 May 2025. The company was registered under the industry Anden teknisk rådgivning. The company has 0 employees (2018). In 2024, the company reported a gross profit of DKK -17,821 and a net result of DKK -18,480 compared with DKK -61,739 the year before. Equity in the 2024 report amounted to DKK 63,032.
